Revista Médica del Instituto Mexicano del Seguro Social

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Revista Médica del Instituto Mexicano del Seguro Social >Year 2017, Issue 5

Pérez-Barragán E, Manjarrez-Tellez B
Tuberculosis caused by Mycobacterium bovis, a re-emerging infection?
Rev Med Inst Mex Seguro Soc 2017; 55 (5)

Language: Español
References: 27
Page: 635-640
PDF: 378.45 Kb.

Full text


Currently, tuberculosis (TB) is a public health problem, is present in all regions of the world and remains one of the most deadly communicable diseases, particularly associated with infection by the human immunodeficiency virus (HIV). Cases of TB Mycobacterium bovis more and more frequent, especially in vulnerable populations. TB caused by M. bovis clinical, radiological and histologically indistinguishable from tuberculosis caused by M. tuberculosis; however, there are some differences that make M. tuberculosis particular. The direct correlation between infection with M. bovis in cattle and human disease has been well documented, but the true prevalence is underestimated. Overall, the proportion of cases of human TB caused by M. bovis is low compared with M. tuberculosis, but its potential in the groups most at risk impact should not be underestimated by the impact on morbidity and mortality.

Key words: Tuberculosis, Mycobacterium bovis, Infection.


  1. Ospina S. La tuberculosis, una perspectiva históricoepidemiológica. Infectio. 2001;5:241-250.

  2. Holloway KL, Henneberg RJ, de Barros Lopes M, Henneberg M. Evolution of human tuberculosis: A systematic review and metaanalysis of paleopathological evidence. Homo. 2011;62(6):402-58.

  3. Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis. 2001;81:71-7.

  4. LoBue PA, Enarson DA, Thoen CO. Tuberculosis in humans and animals: An overview. Int J Tuberc Lung Dis. 2010;14:1075-8.

  5. Cosivi O, Grange JM, Daborn CJ, Raviglione MC, Fujikura T, Cousins D et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis. 1998;4(1):59-70.

  6. Keating LA, Wheeler PR, Mansoor H, Inwald JK, Dale J, Hewinson RG et al. The pyruvate requirement of some members of the Mycobacterium tuberculosis complex is due to an inactive pyruvate kinase: implications for in vivo growth. Mol Microbiol. 2005;56:163-174.

  7. Pan-American Health Organization/World Health Organization. Manual para el diagnóstico bacteriológico de la tuberculosis. Normas y Guía Técnica. Parte II: Cultivo, 2008. Washington DC, USA: PAHO; 2008.

  8. World Health Organization. Global Tuberculosis Report 2014. Geneve, Switzerland: WHO; 2014.

  9. World Health Organization. Global Tuberculosis Report 2015. Geneve, Switzerland: WHO; 2015.

  10. Secretaría de Salud. Programa de Acción Específico (PAE) 2007-2012, Tuberculosis. Primera ed. México: Secretaría de Salud; 2008.

  11. Secretaría de Salud. Perfil epidemiológico de la Tuberculosis en México. México: Secretaria de Salud; 2012.

  12. Michel AL, Müller B, van Helden PD. Mycobacterium bovis at the animal-human interface: a problem, or not? Vet Microbiol. 2010;140(3-4):371-81.

  13. de Kantor IN, LoBue PA, Thoen CO. Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America and the Caribbean. Int J Tuberc Lung Dis. 2010;14(11):1369-1373.

  14. Müller B, Dürr S, Alonso S, Hattendorf J, Laisse CJ, Parsons SD. Zoonotic Mycobacterium bovisinduced tuberculosis in humans. Emerg Infect Dis. 2013;19(6):899-908.

  15. Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, Morlock GP et al. Human tuberculosis due to Mycobacterium bovis in the United States, 1995–2005. Clin Infect Dis. 2008;47(2):168-75.

  16. Gallivan M, Shah N, Flood E. Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011. Emerg Infect Dis. 2015;21(3):435-43.

  17. de Kantor IN, Ambroggi M, Poggi S, Morcillo N, Da Silva-Telles MA, Osorio-Ribeiro M et al. Human Mycobacterium bovis infection in ten Latin American countries. Tuberculosis. 2008;88(4):358-365.

  18. Bobadilla-del Valle M, Torres-González P, Cervera- Hernández ME, Martínez-Gamboa A, Crabtree- Ramirez B, Chávez-Mazari B et al. Trends of Mycobacterium bovis Isolation and First-Line Antituberculosis Drug Susceptibility Profile: A Fifteen- Year Laboratory-Based Surveillance. PLoS Negl Trop Dis. 2015;9(9):e0004124.

  19. Torres-Gonzalez P, Soberanis-Ramos O, Martinez- Gamboa A, Chavez-Mazari B, Barrios-Herrera MT, Torres-Rojas M. et al. Prevalence of latent an d active tuberculosis among dairy farm workers exp osed to cattleinfected by Mycobacterium bovis. PLoS Negl Trop Dis. 2013;7(4):e2177.

  20. Cicero R, Olivera H, Hernandez-Solis A, Ramírez- Casanova E, Escobar-Gutierrez A. Frequency of Mycobacterium bovis as an etiologic agent in extrapulmonary tuberculosis in HIV-positive andnegative Mexican patients. Eur J Clin Microbiol Infect Dis. 2009;28(5):455-60.

  21. Park D, Qin H, Jain S, Preziosi M, Minuto JJ, Mathews WC et al. Tuberculosis due to Mycobacterium bovis in patients coinfected with human immunodeficiency virus. Clin Infect Dis. 2010;51:1343-6.

  22. Cicero R, Olivera H, Hernández-Solís A, Ramírez- Casanova E, Escobar-Gutiérrez A. Frequency of Mycobacterium bovis as an etiologic agent in extrapulmonary tuberculosis in HIV-positive andnegative Mexican patients. Eur J Clin Microbiol Infect Dis. 2009;28(5):455-60.

  23. Portillo-Gómez L, Sosa-Iglesias EG. Molecular identification of Mycobacterium bovis and the importance of zoonotic tuberculosis in Mexican patients. Int J Tuberc Lung Dis. 2011;15(10):1409-14.

  24. Rustomjee R., Lienhardt C., Kanyok T., Davies G.R., Levin, J., Mthiyane T., et al. Gatifloxacin for TB (OFLOTUB), Study Team. A phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2008;12:128-138.

  25. Parreiras PM, Lobato FC, Alencar AP, Figueiredo Td, Gomes HM, Boéchat N, et al. Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques. Mem Inst Oswaldo Cruz. 2004;99(7):749-52.

  26. Vazquez-Chacón CA, Martínez-Guarneros A, Couvin D, González-Y-Merchand JA, Rivera- Gutierrez S, Escobar-Gutierrez A et al. Human multidrug-resistant Mycobacterium bovis infection in Mexico. Tuberculosis. 2015;95(6):802-9.

  27. LoBue PA, Moser KS. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego C ounty,California, United States, 1994-2003. Int J Tuberc Lung Dis. 2005;9(3):333-8.

>Journals >Revista Médica del Instituto Mexicano del Seguro Social >Year 2017, Issue 5

· Journal Index 
· Links 

Copyright 2019